This page is not the official website. Generated by AI, does not constitute any advice. If needed, please click here to visit the corresponding official website.

Gipfel Biotechnology
Pioneering the Future of Medicine

Founded in 2023 in Hangzhou, China, Gipfel Biotech leverages cutting-edge AI platforms and deep scientific expertise to develop novel therapeutics for unmet medical needs.

Biotech Lab Research
Gipfel Biotech Lab

About Gipfel Biotech

Founded in 2023 in Hangzhou, China, Gipfel Biotechnology is driven by a youthful, passionate, and highly skilled team with extensive experience in drug research and development. Our profound understanding of pathological mechanisms enables us to innovate with precision and purpose.

We collaborate with leading AI drug discovery platforms and advanced pharmaceutical companies to ensure highly effective and low-risk development of medical solutions and novel drugs.

Featured Recognition

GBI Interview

GBI Interview (CPB Vol.195)

Insights into our vision and scientific approach.

Pipeline & Product Portfolio

Each project has the potential to be developed as an independent technical area with a wide range of products. Our early-stage pipeline spans multiple therapeutic areas with high unmet need.

Oncology Therapeutics

Novel Oncology Agents

Small molecule inhibitors targeting key pathways in solid tumors and hematological malignancies.

  • Targeting tumor microenvironment
  • AI-optimized pharmacokinetics
  • High specificity, low toxicity
Fibrotic Disease Therapy

Anti-Fibrotic Therapeutics

Innovative compounds for chronic fibrotic diseases affecting liver, lung, and kidney.

  • Modulation of TGF-β signaling
  • Reduction of extracellular matrix deposition
  • Oral bioavailability
💊

Hyperuricemia Drugs

Next-generation urate-lowering agents for gout and metabolic syndrome.

  • Inhibition of xanthine oxidase
  • Improved renal safety profile
  • Potential for once-daily dosing
🛡️

Therapeutic Rhinitis Vaccine

Immunomodulatory vaccine targeting allergic rhinitis with long-term remission potential.

  • Peptide-based antigen design
  • AI-driven epitope prediction
  • Subcutaneous delivery system
🧬

Autoimmune Disease Vaccines

Therapeutic vaccines for autoimmune conditions such as rheumatoid arthritis and lupus.

  • Tolerance induction strategy
  • Targeted immune regulation
  • Reduced reliance on immunosuppressants
🔬

AI-Driven Drug Discovery Platform

Proprietary computational engine for rapid identification and optimization of lead compounds.

  • Deep learning for target validation
  • Generative chemistry models
  • Virtual screening at scale
💊

Preventive Infectious Disease Vaccines

Next-gen preventive vaccines leveraging novel adjuvants and delivery systems.

  • Broad-spectrum protection
  • Thermostable formulations
  • Needle-free administration options
🧪

Personalized Cancer Vaccines

Neoantigen-based vaccines tailored to individual tumor mutational profiles.

  • Whole-exome sequencing integration
  • Machine learning for neoantigen prediction
  • Combination with checkpoint inhibitors
💊

Neuroinflammation Modulators

Small molecules targeting neuroinflammatory pathways in neurodegenerative diseases.

  • Blood-brain barrier permeability
  • Microglial regulation
  • Potential in Alzheimer’s and MS
🧫

Microbiome-Based Therapeutics

Live biotherapeutic products (LBPs) for immune and metabolic disorders.

  • Engineered probiotic strains
  • Targeted metabolite production
  • Oral delivery with gastric protection

Our Vision

"Explore uncharted territories in medicine to create a healthy and beautiful world."

At Gipfel Biotech, we believe that the next frontier of medicine lies at the intersection of biology, artificial intelligence, and human ingenuity. Our vision drives every decision, from target selection to partnership development.

Future Business Segments

💊

Novel Small Molecule Drugs

Focused on oncology, fibrosis, metabolic disorders, and neuroinflammation with AI-enhanced discovery and development.

🛡️

Vaccines

Preventive vaccines for infectious diseases and therapeutic vaccines for allergies and autoimmune conditions using cutting-edge antigen design.

Strategic Cooperation

Through successful collaboration, Gipfel has built broad and consolidated alliances with universities, research centers, production and marketing facilities, drug chain management, and drug sales platforms.

Each partnership continues to bring us closer toward our mission and turns our strategic vision into reality.

  • • Academic & Research Institutions
  • • Contract Research Organizations (CROs)
  • • Contract Development and Manufacturing Organizations (CDMOs)
  • • AI & Computational Biology Platforms
  • • Global Distribution & Sales Networks
Collaboration in Biotech
2023
Founded
10+
Pipeline Projects
8
Therapeutic Areas
50+
Scientific Collaborators

Frequently Asked Questions

What is Gipfel Biotech’s core focus?

We focus on AI-driven discovery of novel small molecule drugs and therapeutic vaccines for oncology, fibrosis, autoimmune diseases, and metabolic disorders.

Where is Gipfel Biotech located?

Our headquarters is in Hangzhou, China: 902, Building 30, No.3300, Benjing Avenue, Xiaoshan District, Hangzhou City, Zhejiang Province.

How can I collaborate with Gipfel Biotech?

We welcome partnerships in research, manufacturing, and commercialization. Please visit our official website to explore collaboration opportunities.

Is Gipfel Biotech hiring?

We are always looking for talented scientists and professionals. Check our official website for current openings.

Get In Touch

For inquiries, collaborations, or more information about our pipeline and technologies, please reach out.

Contact Information

📍

Address:
902, Building 30, No.3300, Benjing Avenue,
Xiaoshan District, Hangzhou City,
Zhejiang Province, China

✉️

Email:
[email protected]

📞

Phone:
+86-193-5760-6325

Notice for Buyers: If you are a buyer, the above information is generated by AI collection and does not constitute any advice. If necessary, please visit the corresponding official website.

For Domain Owners: If you are the domain owner and do not want to be included by fobcompany.info, please contact [email protected] via your corporate email to cancel. We will cancel your inclusion within 3 business days.

如果您是域名所有者 不想被fobcompany.info收录 请用企业邮箱联系[email protected] 取消收录 我们将在3个工作日取消您的收录

Service Request: If you are other domain and want to be included, please contact [email protected]

如果您是其他域名合作 也请联系[email protected]